Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high14.4000 06/03/17
52 week low6.8500 18/10/17
52 week change -2.3750 (-25.00%)
4 week volume12,305,145 22/09/17

Media for (NIPT)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Premaitha Health expands in Middle East

Premaitha Health has signed contracts with three additional laboratories in the Middle East. It is anticipated thee new labor...

Middle East Update

RNS Number: 4988T Premaitha Health PLC 13 October 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Commercial progress in the Middle East Manchester, UK - 13 October 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces further commercial ...

Final Results

RNS Number: 1752S Premaitha Health PLC 29 September 2017 Premaitha Health PLC (" Premaitha, " the "Company" or the "Group") Full year results to 31 March 2017 and half-year trading update Manchester, UK - 29 September 2017: Premaitha ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), an...

Notice of AGM

RNS Number: 1743S Premaitha Health PLC 29 September 2017 Premaitha Health PLC Notice of Annual General Meeting Manchester, UK - 29 September 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing, announces that its annual general meeting will be held at 2:00 p.m. on 24 Oct...

Holding(s) in Company

RNS Number: 4847R Premaitha Health PLC 21 September 2017 Premaitha Health plc ("Premaitha" or the "Company") Holding(s) in Company Following the acquisition by Canaccord Genuity Group of Hargreaves Hale Ltd, the Company has received notification that Canaccord Genuity Group now has a holding of 12,152,385 in Premaitha as per TR-1 form below. TR...

Premaitha to offer NIPT in South Africa

RNS Number: 0824R Premaitha Health PLC 19 September 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Premaitha to offer NIPT in South Africa Manchester, UK - 19 September 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing, announces that it has signed an a...

Further Patent Infringement Claims

RNS Number: 1506Q Premaitha Health PLC 07 September 2017 Premaitha Health plc ("Premaitha" or the "Company") Further patent infringement claims received from Illumina & Sequenom Manchester, UK - 7 September 2017: Premaitha Health plc (AIM: NIPT) announces that it has today received notification from Illumina and Sequenom that a further claim f...

Premaitha's Down's syndrome test approved in Brazil

Premaitha Health's IONA test has been approved for Brazilian Good Manufacturing Practice (B-GMP) by Brazil's regulato...

Fundamental DataMore

EPS-3
Dividend yield0 %

Latest discussion posts More

  • Middle East Expansion

    This can only fly, surely, when the litigation weight is lifted. Allow us to dream, what do others think it will get to when the legal shenanigans are complete. Mr P
    13-Oct-2017
    Mr Papillon
  • Re: Results.

    Based on these results, I am aghast as to why the share price is languishing still below the ten pence mark. It can only be the litigation that is suppressing this share ...
    2-Oct-2017
    Mr Papillon
  • Results.

    Premaitha Health PLC ("Premaitha," the "Company" or the "Group") Full year results to 31 March 2017 and half-year trading update Manchester, UK - 29 ...
    29-Sep-2017
    Disorder

Users' HoldingsMore

Users who hold Premaitha Health also hold..
LLOYDS GRP.20%
ROCKHOPPER18%
GULF KEYSTONE15%
RANGE RES.13%
ID:ISIN:VGG9828A119412%

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT